🔓
Sign in as a Member to unlock the full view of NTLA. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
NTLA

Intellia Therapeutics, Inc.

Sector: healthcareBiotechnologyNASDAQMarket Cap: $1.46B

Pre-revenue biotech with zero political influence, no government ties, no insider clusters, and no recent congressional positioning per tools.

Next filing → your inbox
Govt Dependence
0/100
Regulatory Density
70/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat NTLA does

Intellia Therapeutics, Inc. (NTLA) is a biotechnology company in the healthcare sector with no reported annual revenue.

12 months past · 3 months futureNTLA activity timeline

$18$13$8 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $17.84 hi $8.04 lo $9.86 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 5 ARK Investment Management · + $286M · 2026-06-30ARK Investment Management · - $192M · 2026-09-30ARK Investment Management · OPENED $186M · 2026-03-31D.E. Shaw & Co. · + $109M · 2026-06-30Two Sigma Investments · + $89M · 2026-06-30D.E. Shaw & Co. · + $73M · 2026-03-31Two Sigma Investments · + $60M · 2026-03-31D.E. Shaw & Co. · + $46M · 2025-12-31Two Sigma Investments · + $24M · 2025-12-31Renaissance Technologies · OPENED $24M · 2026-06-30Renaissance Technologies · + $15M · 2025-12-31Citadel Advisors · + $14M · 2026-03-31Citadel Advisors · - $13M · 2026-06-30Point72 Asset Management · + $9M · 2026-06-30AQR Capital Management · - $8M · 2026-06-30AQR Capital Management · OPENED $8M · 2026-03-31 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 0 congressional trades shown · 0 insider buys · 16 13F filings · 0 past bill actions · 5 upcoming markups

Lifetime Government AwardsNTLA federal contracts

NTLA doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding NTLA

$427.7M
Total NTLA held by tracked 13F funds
7
Funds with NTLA positions
ARK Investment Management $192M -6% 2026-09-30
D.E. Shaw & Co. $109M +12% 2026-06-30
Two Sigma Investments $89M +11% 2026-06-30
Citadel Advisors $13M -29% 2026-06-30
Point72 Asset Management $9M +83% 2026-06-30
AQR Capital Management $8M -22% 2026-06-30
Renaissance Technologies $7M -58% 2026-09-30

Congressional TradesWho in Congress is trading NTLA

2023-08-25 Thomas Carper D-Delaware · senate sale $1,001 - $15,000
2023-08-25 Thomas Carper D-Delaware · senate Sale (Full) $1,001 - $15,000
2023-05-22 Thomas Carper D-Delaware · senate purchase $1,001 - $15,000
2023-05-22 Thomas Carper D-Delaware · senate Purchase $1,001 - $15,000
2022-02-28 Donald S. Beyer D-Virginia · house sale $15,001 - $50,000
2022-02-28 Donald S. Beyer D-Virginia · house Sale $15,001 - $50,000
2021-10-29 Donald S. Beyer D-Virginia · house sale $1,001 - $15,000
2021-10-29 Donald S. Beyer D-Virginia · house Sale $1,001 - $15,000
2021-09-20 Donald S. Beyer D-Virginia · house sale $1,001 - $15,000
2021-09-20 Donald S. Beyer D-Virginia · house Sale $1,001 - $15,000
2021-07-21 Donald S. Beyer D-Virginia · house sale $1,001 - $15,000
2021-07-21 Donald S. Beyer D-Virginia · house Sale $1,001 - $15,000
30+ trades on file · most recent 2023-09-05

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

Stock awards & option exercises

1
stock awards · $2.2M market value
2026-10-26 Marantz Jing L. EVP, Chief Medical Officer AWARD 199,822 sh $2.2M
For NTLA, executives receive stock primarily as compensation rather than via open-market purchases — typical for established large-cap firms.

Political ProfileWhere NTLA sits in Washington

No lobbying spend, donations, or influence patterns per get_political_influence (score 0). No insider buys or clusters per get_corporate_insider_signal (tier F, score 0).

Member intelligence layer

Live signals + predictions for NTLA — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout NTLA & political exposure

Does Intellia Therapeutics, Inc. (NTLA) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Intellia Therapeutics, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded NTLA stock?
30 congressional trades by 3 unique members of Congress, most recently on 2023-08-25. See the Congressional Trading panel for politician-by-politician breakdown.
What is NTLA political risk profile?
Government dependence: 0/100. Lobbying intensity: 0/100. Political signal: neutral.
How does GovGreed track NTLA political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. NTLA data is updated daily from these official federal sources.